Clinical Trial Update: A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of belimumab in adult participants with early systemic lupus erythematosus and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: RECRUITING